NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹105.33 | ₹77.56 | ₹39.19 | ₹9.32 | ₹24.16 |
What is the latest Earnings Per Share (EPS) of NATCO PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹105.33 |
| Mar2024 | ₹77.56 |
| Mar2023 | ₹39.19 |
| Mar2022 | ₹9.32 |
| Mar2021 | ₹24.16 |
How is Earnings Per Share (EPS) of NATCO PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹105.33 | 35.80 | |
| Mar2024 | ₹77.56 | 97.91 | |
| Mar2023 | ₹39.19 | 320.49 | |
| Mar2022 | ₹9.32 | -61.42 | |
| Mar2021 | ₹24.16 | - | |
Compare Earnings Per Share (EPS) of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹17,131.8 Cr | -4.6% | 12.4% | 23.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -4.6% |
12.4% |
23.2% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses